WYMM Tour: Stockholm

March 7, 2024, 10:00 AM - 5:00 PM
Stockholm, Sweden

WYMM Tour: Stockholm

07 March 2024, 10:00 - 16:45 CET - Stockholm, Sweden

Generate ultra-rich data for answers with impact.

Who says you can’t see it all? With a comprehensive view of structural variants and methylation, nanopore technology powers the bigger and bolder research questions you’ve always wanted to ask.​​

Join us on Thursday 7th March 2024 in Stockholm to hear from local experts who are breaking new ground in human genomics, using nanopore technology.​​​

What you're missing matters. Stay on top of what's next.​

Aside from talks ranging from human genomics for rare disease, to sequencing for cancer research, the full-day agenda will include networking breaks, Q&A, product displays, and opportunities to engage with your peers and nanopore experts.

Please note that this is an in-person event.

There is no delegate fee for this event, but registration is required. Lunch and refreshments will be provided. Your place at this event will be confirmed via email from events@nanoporetech.com.

Registration

Agenda

Agenda

10:00 – 20:00 hrs CET

Agenda (subject to change)

10:00 – 10:45 hrs

Registration, breakfast and networking

10:45 – 11:10 hrs

What you're missing matters: Catching the unnoticed

Tonya McSherry, Oxford Nanopore Technologies

11:10 – 11:35 hrs

Large-scale methylation studies using Oxford Nanopore sequencing

Brynja Sigurpálsdóttir, deCODE genetics

11:35 – 12:00 hrs

Leveraging long read sequencing to resolve complex structural variants in cancer genomes

Joachim Weischenfeld, Biotech Research & Innovation Centre (BRIC), University of Copenhagen

12:00 – 13:15 hrs

Lunch

13:15 – 13:40 hrs

Oxford Nanopore Technologies bioinformatics update

Stephen Rudd, Oxford Nanopore Technologies

13:40 – 14:05 hrs

Long-read DNA sequencing to identify disease-causing genetic variation

Anna Lindstrand, Karolinska University Hospital

14:05– 14:30 hrs

Characterisation of novel splicing events across brain tissues and during development

Wilfried Haerty, Earlham Institute

14:30 – 15:30 hrs

Networking session

15:30 – 16:05 hrs

Panel discussion: The future of nanopore sequencing in clinical research

Moderated by Chris Swagell, Oxford Nanopore Technologies

16:05 – 16:35 hrs

Rapid molecular diagnostics using nanopore sequencing in patients with CNS tumors

Henning Leske, Department of Pathology, Rikshospitalet

16:35 – 16:45 hrs

Closing remarks

Oxford Nanopore Technologies

16:45 – 20:00 hrs

Drinks reception

Speakers

picture of Brynja Sigurpálsdóttir

Large-scale methylation studies using Oxford Nanopore sequencing

Brynja Sigurpálsdóttir, deCODE

I'm a research associate at deCODE genetics, concurrently pursuing my PhD at Reykjavík University. M...

picture of Joachim Weischenfeld

Leveraging long read sequencing to resolve complex structural variants in cancer genomes

Joachim Weischenfeld, BRIC, University of Copenhagen

Affiliation: BRIC/Finsen Laboratory, Rigshospitalet and BRIC, University of Copenhagen Short Bio: P...

picture of Anna Lindstrand

Long-read DNA sequencing to identify disease-causing genetic variation

Anna Lindstrand, Karolinska University Hospital

Prof. Anna Lindstrand, a Clinical Genetics consultant and Director at Karolinska University Hospital...

picture of Henning Leske

Rapid molecular diagnostics using nanopore sequencing in patients with CNS tumors

Henning Leske, Rikshospitalet

After studying medicine at the LMU in Munich i started my specialization i Neuropathology in Zurich,...

picture of Wilfried Haerty

Characterisation of novel splicing events across brain tissues and during development

Wilfried Haerty, Earlham Institute

I completed my PhD in 2004 (University Paris VI), followed by postdocs at McMaster University (Hamil...